These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10190387)

  • 1. Systemic inflammatory reaction after starting highly active antiretroviral therapy in AIDS patients treated for extrapulmonary tuberculosis.
    Furrer H; Malinverni R
    Am J Med; 1999 Mar; 106(3):371-2. PubMed ID: 10190387
    [No Abstract]   [Full Text] [Related]  

  • 2. [Managements of tuberculosis complicated with HIV infection and AIDS].
    Xiao H; He G
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Nov; 23(11):659-62. PubMed ID: 11225028
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiretroviral rounds. When success is a pain.
    Bartlett JG; del Rio C
    AIDS Clin Care; 2001 Aug; 13(8):74-5. PubMed ID: 11547461
    [No Abstract]   [Full Text] [Related]  

  • 4. Uveitis following administration of the protease inhibitor indinavir to a patient with AIDS.
    Gariano RF; Cooney EL
    Clin Infect Dis; 1997 Mar; 24(3):529. PubMed ID: 9114223
    [No Abstract]   [Full Text] [Related]  

  • 5. Protease inhibitors and blood sugar problems.
    TreatmentUpdate; 2001 Jun; 13(2):8. PubMed ID: 11570291
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection.
    Benator DA; Weiner MH; Burman WJ; Vernon AA; Zhao ZA; Khan AE; Jones BE; Sandman L; Engle M; Silva-Trigo C; Hsyu PH; Becker MI; Peloquin CA;
    Pharmacotherapy; 2007 Jun; 27(6):793-800. PubMed ID: 17542762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study.
    Périard D; Telenti A; Sudre P; Cheseaux JJ; Halfon P; Reymond MJ; Marcovina SM; Glauser MP; Nicod P; Darioli R; Mooser V
    Circulation; 1999 Aug; 100(7):700-5. PubMed ID: 10449690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperlipidemia associated with the use of protease inhibitors.
    Smith JH; Martin GJ; Decker CF
    Clin Infect Dis; 2000 Jul; 31(1):207-8. PubMed ID: 10913432
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypercholesterolemia in a health care worker receiving thyroxine after postexposure prophylaxis for human immunodeficiency virus infection.
    Nerad JL; Kessler HA
    Clin Infect Dis; 2001 Jun; 32(11):1635-6. PubMed ID: 11340537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Focal mycobacterial lymphadenitis after starting highly active antiretroviral therapy].
    Schwietert M; Battegay M
    Dtsch Med Wochenschr; 1999 Jan; 124(3):45-8. PubMed ID: 9987485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe anoxic hepatic necrosis in an HIV-1-hepatitis C virus-co-infected patient starting antiretroviral triple combination therapy.
    Karras A; Rabian C; Zylberberg H; Hermine O; Duchatelle V; Durand F; Valla D; Viard JP
    AIDS; 1998 May; 12(7):827-9. PubMed ID: 9619823
    [No Abstract]   [Full Text] [Related]  

  • 12. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
    Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
    N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indinavir-induced renal failure.
    Chen SC; Nankivell BJ; Dwyer DE
    AIDS; 1998 Mar; 12(4):440-1. PubMed ID: 9520176
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of disseminated tuberculosis and acquired immunodeficiency syndrome in an 81-y-old woman.
    Laszlo A; Gianelli S; Laurencet F; Krause KH; Janssens JP
    Scand J Infect Dis; 2003; 35(6-7):420-2. PubMed ID: 12953961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes after early initiation of antiretroviral therapy for human immunodeficiency virus-associated tuberculosis.
    Chan CK; Wong KH; Leung CC; Tam CM; Chan KC; Pang KW; Chan WK; Mak IK
    Hong Kong Med J; 2013 Dec; 19(6):474-83. PubMed ID: 23926173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS research. Bioethicists assail a celebrated TB/HIV treatment trial.
    Cohen J
    Science; 2010 May; 328(5980):799-801. PubMed ID: 20466890
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug resistance mutations in HIV-1-infected subjects during protease inhibitor-containing highly active antiretroviral therapy with nelfinavir or indinavir.
    Yerly S; Rickenbach M; Popescu M; Taffe P; Craig C; Perrin L;
    Antivir Ther; 2001 Sep; 6(3):185-9. PubMed ID: 11808753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.
    Williams BG; Dye C
    Science; 2003 Sep; 301(5639):1535-7. PubMed ID: 12920302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indinavir nephropathy in an AIDS patient with renal insufficiency and pyuria.
    Perazella MA; Kashgarian M; Cooney E
    Clin Nephrol; 1998 Sep; 50(3):194-6. PubMed ID: 9776425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abacavir (1592) with protease inhibitors in potent antiretroviral activity.
    AIDS Patient Care STDS; 1998 Apr; 12(4):315-6. PubMed ID: 11361959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.